A retrospective study to evaluate the effect of early conversion to everolimus together with prophylaxis with valganciclovir in the prevention of cytomegalovirus infection in heart transplant recipients

Trial Profile

A retrospective study to evaluate the effect of early conversion to everolimus together with prophylaxis with valganciclovir in the prevention of cytomegalovirus infection in heart transplant recipients

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Dec 2015

At a glance

  • Drugs Everolimus (Primary) ; Ganciclovir; Valganciclovir
  • Indications Cytomegalovirus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 30 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top